ArticleInternational journal of molecular sciences2023

Domatinostat Targets the FOXM1-Survivin Axis to Reduce the Viability of Ovarian Cancer Cells Alone and in Combination with Chemotherapeutic Agents.

Yurika Nakagawa-Saito et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.